All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Article

Equipment and Processing Report

February 20, 2008

Equipment and Processing Report

Equipment and Processing Report-02-20-2008
Volume0
Issue 0

February 2008 Editor's Picks

Author(s):

Pharmaceutical Technology Editors

Featured products from this issue of Equipment & Processing Report

Optima Group Pharma
Nested syringe filler operates at high speed

The “H10-16” nested syringe-filling and -closing machine from Optima Group Pharma (Green Bay, WI) provides high-speed operation and on line fill-weight checking. Uwe Kellermann, vice-president of pharmaceutical applications for the company, says, “In the 160-nest configuration, the [unit’s] output is 960 syringes/min.” He adds that the device processes six tubs per minute, regardless of the nest configuration.

The H10-16 machine is equipped with a proprietary in-process control (IPC) system. The IPC system performs fill checks by removing one row of syringes, weighing it before and after filling, and providing automatic feedback to the filling system. This nondestructive method allows companies to use or sell all tested syringes.
In addition, the unit incorporates a robot that removes the “Tyvek” cover and layer from tubs before filling and closing.
Kellermann observes that the device accommodates various fill systems, including peristaltic pumps.

Sono-Tek
Spray dryer collects small particles

At INTERPHEX Puerto Rico, Sono-Tek (Milton, NY) unveiled its “SonoDry 1000” spray-drying system. Luis Abarca, director of Sono-Tek’s ultrasonic coating solutions business, explains that the system’s dual-cyclone design “efficiently collects fine particles with high yields to create small batches of spray-dried particles from aqueous or solvent feeds.”

Abarca adds that the nonclogging high-frequency ultrasonic nozzle is core of the system’s technology. The nozzle is available in four frequencies to create customized droplet sizes at low flow rates. The 120 kHz nozzle, for example, creates a median drop size of 18 µm in water.

Articles in this issue

Depyrogenation by Dilution
Consistent Capsule Filling
Sono120x196-492221-1408676704432.jpg
February 2008 Editor's Picks

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, CSO, AustinPx
Related Content
Advertisement
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 12th 2025

Nxera’s New GLP-1 and GPCR-Targeted Drug Programs Aim to Advance Obesity and Metabolic Disorder Therapies

Feliza Mirasol
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 12th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Pink-white and blue-white capsule pills with concept of precision medicine with nanotechnology, proteomics, and advanced artificial intelligence to enhance diagnostics and patient-specific solutions. | Image Credit: ©Artinun - stock.adobe.com
August 12th 2025

Personalized and Patient-Centric Administration of Oral Medicines

Cynthia A. Challener
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 12th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Skin diseases concept. macro skin of human hand.Medicine and dermatology concept. Details of human skin background. | Image Credit: © daily_creativity - stock.adobe.com
August 12th 2025

Almirall Selects 2nd Dermatology Target in AI Drug Discovery Collaboration with Absci

Patrick Lavery
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 12th 2025

FDA Grants Approval to Celltrion for Expanded Indication of Actemra Biosimilar to Treat CRS

Feliza Mirasol
Related Content
Advertisement
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 12th 2025

Nxera’s New GLP-1 and GPCR-Targeted Drug Programs Aim to Advance Obesity and Metabolic Disorder Therapies

Feliza Mirasol
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 12th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Pink-white and blue-white capsule pills with concept of precision medicine with nanotechnology, proteomics, and advanced artificial intelligence to enhance diagnostics and patient-specific solutions. | Image Credit: ©Artinun - stock.adobe.com
August 12th 2025

Personalized and Patient-Centric Administration of Oral Medicines

Cynthia A. Challener
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 12th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Skin diseases concept. macro skin of human hand.Medicine and dermatology concept. Details of human skin background. | Image Credit: © daily_creativity - stock.adobe.com
August 12th 2025

Almirall Selects 2nd Dermatology Target in AI Drug Discovery Collaboration with Absci

Patrick Lavery
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 12th 2025

FDA Grants Approval to Celltrion for Expanded Indication of Actemra Biosimilar to Treat CRS

Feliza Mirasol
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.